Testosterone

睾酮

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameTestosterone
Drug Alias Name睾丸素testosteronum睾固酮睾丸酮睾甾酮 +[25] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsRejection of renal transplantationSolid tumoursIdiopathie hypogonadotropic hypogonadism +[63] 
Global Approved IndicationsSexual Dysfunctions, PsychologicalHypogonadism
Approved Indications in ChinaHypogonadism
Original Approved Country/TerritoryMainland China
Original Approved Date1980/01/01
Country/TerritoryBelgiumCanadaBotswana +[23] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMarshall B. Ketchum UniversityUniversity Medical Center GroningenUniversity of Sao Paulo +[13] 
Inactive CompaniesAbbott LaboratoriesBüdelpack Hamont NvFbm Industria Brasileira Ltd +[53] 
Active IndicationsRejection of renal transplantationHip FracturesFatigue +[15] 
Inactive IndicationsSolid tumoursIdiopathie hypogonadotropic hypogonadismMenopausal symptoms +[48] 

Other Information

ATC CodeG03BA03
Related LinksWikipediaDrugBankKEGG